Chester County News and Community Website
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently granted accelerated approval for a new treatment combination for adults with KRAS G12C-mutated locally advanced or metastatic colorectal cancer (CRC). …
FDA Grants Accelerated Approval to New Colorectal Cancer Treatment Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adult patients with primary …
FDA Approves Keytruda Combination for Advanced Endometrial Cancer Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced a significant development in its ongoing ABOYA-119 clinical trial. The Safety Review Committee (SRC) has approved the commencement of dosing patients …
Aprea Therapeutics Advances Cancer Treatment Trial to Higher Dose Level Read More
WEST CHESTER, PA — Syapse, a real-world oncology data company, has introduced Syapse Cohorts: Essentials, a new tool aimed at providing cancer researchers and life sciences companies with comprehensive datasets. …
Syapse Launches New Oncology Data Tool to Aid Cancer Research Read More
PHILADELPHIA, PA — March is Kidney Cancer Awareness Month, a time when organizations like MidLantic Urology make an extra effort to educate the public about this serious disease. It’s an …
Kidney Cancer: Awareness, Risks, Treatments and Prevention Read More